Funds and ETFs Virbac

Equities

VIRP

FR0000031577

Pharmaceuticals

Market Closed - Euronext Paris 11:35:12 2024-04-26 am EDT 5-day change 1st Jan Change
349 EUR +0.72% Intraday chart for Virbac -7.18% -2.92%
Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families: - pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: France (15.8%), Europe (24.9%), Asia (17.5%), Latin America (16.2%), North America (13.3%), Pacific (9.7%), Africa and Middle East (2.6%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
349 EUR
Average target price
368 EUR
Spread / Average Target
+5.44%
Consensus

Quarterly revenue - Rate of surprise